Your browser doesn't support javascript.
loading
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45].
Kuhlin, Johanna; Sturkenboom, Marieke G G; Ghimire, Samiksha; Margineanu, Ioana; van den Elsen, Simone H J; Simbar, Noviana; Akkerman, Onno W; Jongedijk, Erwin M; Koster, Remco A; Bruchfeld, Judith; Touw, Daan J; Alffenaar, Jan-Willem C.
Afiliación
  • Kuhlin J; Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sturkenboom MGG; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Ghimire S; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Margineanu I; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • van den Elsen SHJ; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Simbar N; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Akkerman OW; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Jongedijk EM; University of Groningen, University Medical Center Groningen, Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Koster RA; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • Bruchfeld J; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Touw DJ; PRA Health Sciences Bioanalytical Laboratory, Assen, The Netherlands.
  • Alffenaar JC; Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
J Mass Spectrom Adv Clin Lab ; 25: 72, 2022 Aug.
Article en En | MEDLINE | ID: mdl-36035622

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Mass Spectrom Adv Clin Lab Año: 2022 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Mass Spectrom Adv Clin Lab Año: 2022 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Países Bajos